Finding Providers
loading

We found 3 mohs skin cancer surgeons who accept Private Healthcare Systems near Boston, MA.

Showing 1-3 of 3
Dr. Victor Allen Neel, PhD, MD
Specializes in MOHS-Micrographic Surgery
50 Staniford Street; 2nd Floor S50 270
Boston, MA
 

Dr. Victor Neel is a medical specialist in dermatology (skin disorders). Dr. Neel has indicated that his clinical interests include minimally invasive procedures, cosmetic surgery, and mohs surgery. He honors Blue Cross/Blue Shield, Coventry, and Humana ChoiceCare Network, as well as other insurance carriers. He is a graduate of Weill Cornell Medical College and a graduate of Rhode Island Hospital's residency program. Distinctions awarded to Dr. Neel include: Boston Super Doctors and NIH Mstp Fellowship. Dr. Neel (or staff) is conversant in Arabic, Bosnian, and French. His hospital/clinic affiliations include The Miriam Hospital, Rhode Island Hospital, and Massachusetts General Hospital. Dr. Neel is accepting new patients.

Read more

Clinical interests: Cancer Surgery, Cosmetic Surgery, Skin Cancer, Cosmetic Skin Treatment, Mohs Surgery, Academic ... (Read more)

No Photo
Specializes in MOHS-Micrographic Surgery
50 Staniford Street; 2nd Floor
Boston, MA
 

Dr. Jessica Fewkes, who practices in Boston, MA, is a medical specialist in MOHS-micrographic surgery. Her patients gave her an average rating of 4.5 out of 5 stars. She has indicated that her clinical interests include wounds, mohs surgery, and skin cancer. Dr. Fewkes is an in-network provider for several insurance carriers, including Blue Cross/Blue Shield, Coventry, and Humana ChoiceCare Network. She is a graduate of the University of California, San Francisco (UCSF), School of Medicine and a graduate of Massachusetts General Hospital's residency program. Awards and/or distinctions she has received include Boston Super Doctors; Other Specialty:dermatologic Surgery; and National Board Of Directors, Acmmsco. Dr. Fewkes (or staff) speaks French. She also offers interpreting services for her patients. She is affiliated with Massachusetts General Hospital. New patients are welcome to contact Dr. Fewkes's office for an appointment.

Read more

Clinical interests: Wounds, Skin Cancer, Mohs Surgery, Skin Issues, Aging

No Photo
Specializes in MOHS-Micrographic Surgery
50 Staniford Street; 2nd Floor
Boston, MA
 

Dr. Molly Yancovitz's specialty is MOHS-micrographic surgery. Clinical interests for Dr. Yancovitz include skin cancer. The average patient rating for Dr. Yancovitz is 3.5 stars out of 5. Dr. Yancovitz is an in-network provider for Blue Cross/Blue Shield, Coventry, and Humana ChoiceCare Network, in addition to other insurance carriers. She graduated from the University of California, San Francisco (UCSF), School of Medicine and then she performed her residency at NYU Langone Medical Center. She is professionally affiliated with Massachusetts General Hospital. New patients are welcome to contact Dr. Yancovitz's office for an appointment.

Read more

Clinical interests: Skin Cancer, Skin Issues

Conditions / Treatments

Gender

Insurance

Medicare Patient Conditions

Medicare Patient Ethnicity

Additional Information

Distinctions

Foreign Language

Online Communication

Practice Affiliation

Credentials

Medical School

Residency

Years Since Graduation

What is MOHS-Micrographic Surgery?

Mohs micrographic surgery is a surgical treatment for skin cancer that was developed by Dr. Frederick Mohs in the 1930’s. It is the most effective technique for removing the most common types of skin cancer. For the two most common types of skin cancer, basal cell carcinoma and squamous cell carcinoma, Mohs has a 98-99% cure rate. The remarkable thing about Mohs is that it manages to be extremely good at removing all of the cancer cells while at the same time leaving behind most of the healthy tissue, so there is a smaller wound. This makes the procedure safer, speeds up the the recovery time, and minimizes scarring.

During Mohs surgery, skin around the cancer site is mapped out and removed in thin layers. Then each layer is examined under a microscope for cancer cells, while the surgery is in progress. If cancer cells are detected, the surgery continues and another layer is removed. If the skin is clear, the surgery can be stopped. This eliminates the guesswork for surgeons. There is no need to estimate the borders or roots of the cancer and no need to remove a margin of healthy tissue to ensure that all of the cancer is removed.

Even though Mohs has a high cure rate, is safer than other treatments, and takes less tissue, not every skin cancer is treated with Mohs. First, Mohs takes quite a bit longer than traditional surgery because each layer of skin must be carefully cut, prepped, and examined. It is also more expensive and may not always be covered by insurance. In addition, for smaller or less aggressive cancers that are easier to treat, the cure rate for non-Mohs treatments is close to that of Mohs; thus, the extra time and cost of Mohs might not be justified. Other kinds of skin cancer, such as melanoma, are hard to see under a microscope. Since melanoma is so dangerous, Mohs has traditionally not been used to treat it, as there is too much risk for missed cancer cells being left behind in the body. However, recent developments in stains (which make cancer cells more visible under a microscope) may change the role of Mohs in melanoma treatment.

Mohs microsurgery has changed the way doctors treat skin cancer in the past 80 years, and it continues to gain in popularity as it increases the effectiveness and safety of skin cancer treatment.